We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TWFG:NASDAQTWFG, Inc. Analysis

Data as of 2026-05-06 - not real-time

$18.92

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

TWFG is trading at $18.92, far below its DCF‑derived fair value of roughly $100, implying a potential upside of over 35%. The stock sits just above its technical support at $17.73 and below the 20‑day SMA (19.06), with a bearish MACD and a 30‑day volatility of 43%, suggesting short‑term price pressure. Despite a low beta of 0.12, the decreasing volume trend adds liquidity concerns. Fundamentally, the company posted $248.5 M in revenue with a 35.8% growth rate and an impressive 84.9% gross margin, though net profit margin is modest at 3.2% and free cash flow is negative. The balance sheet is modestly leveraged (debt‑to‑equity 4.9) and cash on hand exceeds debt. Analyst consensus remains a “Buy” with a mean target price of $25.7, reinforcing the valuation gap. The combination of strong top‑line growth, high margins, and a substantial undervaluation supports a bullish outlook beyond the immediate technical weakness.
Given the extreme greed sentiment in the market (Fear & Greed Index 90.38) and the stock’s low market cap, investors should weigh the upside potential against the near‑term bearish technicals and cash‑flow constraints. A medium‑ to long‑term position appears attractive, while short‑term exposure warrants caution.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Bearish MACD and price below short‑term SMA
  • Proximity to technical support at $17.73
  • Decreasing volume and negative free cash flow

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Revenue growth of 35.8% and high gross margin
  • DCF fair value indicating >35% upside
  • Analyst consensus “Buy” with $25.7 mean target

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Substantial valuation gap to DCF estimate
  • Low beta and stable US‑centric insurance brokerage model
  • Potential for margin expansion and earnings growth

Key Metrics & Analysis

Financial Health

Revenue Growth35.80%
Profit Margin3.20%
P/E Ratio35.7
ROE13.91%
ROA6.64%
Debt/Equity4.89
P/B Ratio3.4
Op. Cash Flow$53.5M
Free Cash Flow$-35808752
Industry P/E16.6

Technical Analysis

TrendBearish
RSI47.9
Support$17.73
Resistance$20.56
MA 20$19.06
MA 50$19.12
MA 200$24.71
MACDBearish
VolumeDecreasing
Fear & Greed Index90.38

Valuation

Fair Value$99.93
Target Price$25.71
Upside/Downside35.91%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.12
Volatility43.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.